We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Will Continue as Usual If Congress Misses User Fee Deadline, Shuren Says
CDRH Will Continue as Usual If Congress Misses User Fee Deadline, Shuren Says
Carryover funds and an undisclosed contingency plan will keep the FDA’s user fee program in motion even if Congress misses the Sept. 30 deadline for reauthorizing the Medical Device User Fee Amendment (MDUFA V), said FDA’s Jeff Shuren at the recent annual meeting of the Regulatory Affairs Professionals Society (RAPS) in Phoenix.